# Viewpoint Round 3 — Editorial-Policy Reviewer Report

- **Round.** 3
- **Reviewer.** policy (Editorial-Policy Reviewer)
- **Date.** 2026-05-21
- **Manuscript commit.** `be58d8ee91db25a38fa6ec876af359a97918464c`
- **Target journal.** *The Lancet Digital Health*, article type Viewpoint
- **Model.** Anthropic Claude Opus 4.7 (1M-context variant), Claude Code dispatch

## Sources consulted (Round 3)

- `manuscript/main.tex` (v0.4.1, HEAD `be58d8e`)
- `manuscript/references.bib`
- `manuscript/JOURNAL.md`
- `manuscript/cover-letter.md`
- `docs/ai-usage-disclosure.md`
- `docs/disclosure2-schema.json`
- `docs/design.md`
- `reviewer-logs/viewpoint-round-02/response-to-reviewers.md`
- `reviewer-logs/viewpoint-round-02/policy.md` (own R2 transcript)
- `reviewer-logs/viewpoint-round-02/decisions.json`
- `reviewer-logs/viewpoint-round-01/policy.md` (own R1 transcript, for regression check)

## Overall impression

The v0.4.1 revision closes the last policy-relevant tightening that was open at end of Round 2. The word-count discrepancy I raised as N1 is gone: `manuscript/main.tex` line 60 now declares "Body word count. 2,281" and `manuscript/cover-letter.md` line 58 declares "2 281"; a desk editor reading both documents now sees one number. N2 (`lintom2026`, `linehs2024` verification-pending notes in `references.bib`) and N3 (`JOURNAL.md` interpretive sentence) remain in place; both are appropriately logged as operator-step items in `reviewer-logs/viewpoint-round-02/response-to-reviewers.md` and neither is a policy mis-statement. N2 is a release-time bibliographic step (the operator commits to live verification at submission); N3 is the operator's own working interpretation in a file that does not propagate into Editorial Manager metadata.

The 10 R1 comments closed in Round 2 (C1 verbatim policy quotation; C2 reviewer-AI prohibition and symmetric replacement framing; C3 90-day Editorial Manager pilot path; C4 equity-paragraph plus minimum viable manifest; C5 three forward references empirically anchored by three new artefacts; C6 No-AI-as-author sentence; C7 audit split 5a/5b/5c; C8 SHA filled, macro removed; C9 three harms named with citations; C12 distributional-reproducibility operationalised at n=3 with bootstrap-CI threshold) are still in place at HEAD `be58d8e`. I verified each by re-reading the cited lines of `main.tex`, `references.bib`, `JOURNAL.md`, `docs/disclosure2-schema.json`, and `docs/ai-usage-disclosure.md`. No regression.

The acceptance criterion in my persona prompt — every previous-round blocker- or high-severity policy comment resolved, no mis-quotation of policy text remains, and the implementability path concrete enough for an editorial board to evaluate as a pilot — is satisfied. The Lancet group's permitted-uses phrase ("readability and language improvements only") and prohibited-uses sentence ("generate scientific arguments, draft methodology descriptions, write literature reviews, or create new content") are quoted verbatim in §1 with a retrieval-dated reference entry `lancetaipolicy2024` carrying "Retrieved 2026-05-20". The reviewer-side prohibition is quoted in §6 recommendation 3 and reframed as a bilateral lift, not a one-sided ask. The Disclosure 2.0 manifest items are mapped to a JSON Schema (`docs/disclosure2-schema.json`) whose draft-2020-12 conformance and per-item coverage I re-verified at HEAD; the minimum viable variant (items 1, 2, 3, 6) is documented both in the manuscript at §3 line 116 and consistent with the schema's `required` array. The 90-day pilot path in §6 recommendation 1 (PDF alongside cover letter, editorial-office verification against the linked Zenodo DOI, 5–10 LDH submissions per quarter) is implementable without Aries Systems feature work.

My verdict is **`accept`**.

---

## Round 2 new-comment status (verified)

### N1 — `low` — Word-count inconsistency — **closed**

`manuscript/main.tex` line 60: *"Body word count. 2,281 (texcount body sections only, exclusive of Key Messages, Search Strategy and Declarations; full texcount sum count 3,175)"*. `manuscript/cover-letter.md` line 58: *"Body word count | 2 281 (texcount, body sections only; under the 2 500 ceiling)"*. The two numbers now match. The full-document `texcount` sum (3,175) is also displayed in the title-page metadata so a desk editor cross-checking against `texcount -inc -sum` will reconcile both. Resolved.

### N2 — `low` — `references.bib` verification-pending notes — **deferred (acceptable)**

`lintom2026` and `linehs2024` retain the notes I flagged in R2. The R2 response-to-reviewers (`reviewer-logs/viewpoint-round-02/response-to-reviewers.md` line 18) explicitly logs both as operator-step at submission release. Live verification against PubMed / arXiv at the live submission moment is the appropriate close-out path; it is not the manuscript's policy axis. No further policy intervention required.

### N3 — `low` — `JOURNAL.md` interpretive sentence — **deferred (acceptable)**

`manuscript/JOURNAL.md` lines 102–107 still carry the sentence *"the Disclosure 2.0 proposal lifts both prohibitions in favour of bilateral disclosure"*. This is consistent with §6 recommendation 3 of the manuscript and is appropriate in the operator's working spec. `JOURNAL.md` is not Editorial Manager submission metadata; the cover letter (`manuscript/cover-letter.md` lines 112–122) does not import this sentence. Resolved on the policy axis.

---

## Regression check against the ten R1 comments closed in Round 2

I re-verified each closure at HEAD `be58d8e`:

- **C1 (blocker, policy verbatim quotation).** `main.tex` line 89 reproduces the verbatim phrasing *"readability and language improvements only"* and the prohibited-uses sentence verbatim. Separate provisions for AI-generated images and AI-assisted peer review are in a distinct sentence, and disclosure is located in the Acknowledgements. `references.bib` entry `lancetaipolicy2024` carries the retrieval date 2026-05-20. **Closed.**
- **C2 (high, reviewer-AI prohibition / symmetry).** `main.tex` lines 172 (§6 recommendation 3) names the prohibition explicitly and reframes Disclosure 2.0 as a symmetric replacement. **Closed.**
- **C3 (high, Editorial Manager implementability).** `main.tex` line 168 (§6 recommendation 1) describes the 90-day pilot path with no Editorial Manager feature work required. **Closed.**
- **C4 (high, equity).** `main.tex` line 116 (§3 minimum viable manifest items 1, 2, 3, 6) and line 160 (§5 explicit "well-resourced submitters only" counter-argument plus MIT-licensed forkable repository as worked example). **Closed.**
- **C5 (high, self-undermining demonstration).** `main.tex` line 154 (§5) cites "three forward references to artefacts not yet committed (a re-execution check script, a JSON schema, and a ledger file)" with the resolution path described. The three artefacts (`docs/disclosure2-schema.json`, `docs/ledger.md`, `scripts/regenerate_ledger.py`) are present at HEAD. **Closed.**
- **C6 (medium, authorship-exclusion reinforcement).** Acknowledgements at `main.tex` line 203 contains *"No AI tool is listed as an author of this Viewpoint."* The §6 reinforcement sentence I suggested in R1 remains a non-blocking enhancement; current placement is acceptable. **Closed.**
- **C7 (medium, audit-log conflation).** `main.tex` line 112 splits item 5 into 5a/5b/5c with the explicit clause *"Partial discharge of (5a) alone does not satisfy item 5"*; mirrored in `docs/disclosure2-schema.json` fields `audit.reExecution`, `audit.citationVeracity`, `audit.statisticalReproducibility`, `audit.claimDataAlignment`, `audit.consolidatedFindings`. **Closed.**
- **C8 (medium, placeholder references).** `references.bib` `repoprereg` SHA is `88d6d15`; the `<<HEADLINE:layer3_primary>>` macro is gone from §4. **Closed.**
- **C9 (medium, "literal vs sympathetic" framing).** `main.tex` line 89 names the three harms with citations (`icmje2024`, `luSakana2026`, `zhaoHallucinations2026`). **Closed.**
- **C12 (low, distributional-reproducibility operationalisation).** `main.tex` line 150 specifies n=3 runs, same selected sub-claim and statistical method, headline effect within the original bootstrap 95% CI. **Closed.**

C10 (AMEE Guide) and C11 (peer-reviewed ARS companion) were deferred in R2 as low-severity non-blockers and are not re-raised here.

No regression on any closed comment.

---

## Verdict

**`accept`.**

The acceptance criterion in `prompts/04-viewpoint-reviewer-policy.md` (every previous-round blocker- or high-severity policy comment resolved, no mis-quotation of policy text remains, implementability path concrete enough for an editorial board to evaluate as a pilot) is satisfied at HEAD `be58d8e`. Round 1's blocker C1 and four high-severity comments C2–C5 are resolved; R2's three low-severity new comments are either closed (N1) or appropriately deferred to live submission-day operator steps (N2, N3). No new policy-axis issues surfaced in this round.

Per the user-spec four-round cycle, this is the Round 3 closure pass on the policy axis. Round 4 is the confirmation round; I do not anticipate raising a new policy comment unless an inter-round commit introduces a regression.

Submission-day operator-step items the policy reviewer flags for completeness (not blockers; already enumerated in `reviewer-logs/viewpoint-round-02/response-to-reviewers.md` lines 30–40):

1. Live re-verification of the Lancet DH Information-for-Authors PDF on submission day (HTTP 403 has been observed on three consecutive checks);
2. Resolution of `lintom2026` and `linehs2024` against the live record;
3. Insertion of medRxiv and Zenodo DOIs into the cover letter;
4. Insertion of suggested-reviewer names, affiliations, ORCIDs and e-mails into the cover letter;
5. Branch protection on `main` at the `viewpoint-v1.0.0` tag (per `docs/design.md` line 107);
6. Live IFA word-count and reference-count ceilings cross-check (the operator's working ceiling of 2,500 body words / 30 references is consistent with the secondary sources cited in `manuscript/JOURNAL.md`, but the live PDF has been Cloudflare-gated throughout the revision cycle).

None of these is a policy mis-statement or a substantive manuscript change; all are mechanical submission-day actions.
